Composition and methods for alleviating cystic fibrosis
US4826679A · kind A · utility
75Cited by
4References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 23, 1986 |
| Grant date | May 2, 1989 |
| Priority date | — |
| Expiry date | May 23, 2006 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/465
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an oral composition for alleviating digestive manifestations in patients afflicted with cystic fibrosis, which comprises a therapeutic amount of taurine in association with a pharmaceutically acceptable carrier, and to a method of alleviating digestive manifestations in patients afflicted with cystic fibrosis by the administration of said oral composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.